| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer | EVP, General Counsel
1 company
George Eric Davis is EVP, Chief Legal Officer at BMRN. From June 2016 to September 2026, the filings on record show 0 open-market purchases and 33 sales. The disclosed holdings are worth an estimated $3.4M at current prices.
Our model assigns George Eric Davis a middling insider score of 65/100, based on 13 past trades. Over a 12-month horizon, 58.3% of those trades were profitable, with an average 12-month return of +5.4%.
The BMRN filings lean toward selling, a net 345,212 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sale+OE | 5,000 | $90.42 | $452,100.00 | -6.6% | |
| Aug 1, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 2,167 | $100.00 | $216,700.00 | -3.0% | |
| Jul 7, 2016 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 2,167 | $90.00 | $195,030.00 | -3.0% |